Vinorelbine Tartrate
Overview
Vinorelbine Tartrate is a semi-synthetic vinca alkaloid used to treat certain types of cancer, including non-small cell lung cancer. It works by inhibiting mitosis, thereby preventing the multiplication of cancer cells.
API suppliers (6)
Suppliers of Vinorelbine Tartrate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 6 suppliers.
1 holds a European CEP for this substance
- PIERRE FABRE MEDICAMENTFrance1 active DMF
- MINAKEM HIGH POTENTBelgium1 active DMF
- HUBEI HONCH PHARMACEUTICAL CO LTD1 active DMF
- MINAKEMFranceCEP
- SYNBIAS PHARMA AGFrance
- ALP PHARM BEIJING CO LTD
EU CEP holders (2)
Companies holding a valid EU Certificate of Suitability (CEP) for Vinorelbine Tartrate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Vinorelbine Tartrate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.